ClinicalTrials.gov record
Not listed Phase 2 Interventional

Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse

ClinicalTrials.gov ID: NCT00069966

Public ClinicalTrials.gov record NCT00069966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 2:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin (BSHAP) as Salvage in Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma

Study identification

NCT ID
NCT00069966
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Theradex
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • autologous bone marrow transplantation Procedure
  • cisplatin Drug
  • cytarabine Drug
  • filgrastim Biological
  • methylprednisolone Drug
  • peripheral blood stem cell transplantation Procedure
  • pixantrone dimaleate Drug
  • rituximab Biological

Procedure · Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2003
Primary completion
Not listed
Completion
Not listed
Last update posted
Jul 6, 2009

Started 2003

United States locations

U.S. sites
28
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Arizona Oncology Associates - Craycroft Road Offices Tucson Arizona 85712-2254
City of Hope Comprehensive Cancer Center Duarte California 91010-3000
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90033-0804
Rocky Mountain Cancer Centers - Colorado Springs Colorado Springs Colorado 80933-1181
Rocky Mountain Cancer Centers - Denver Midtown Denver Colorado 80218
Delaware Clinical & Laboratory Physicians Newark Delaware 19713
Pasco, Hernando Oncology Associates, P.A. New Port Richey Florida 34652
Hematology-Oncology Associates of Illinois Chicago Illinois 60611-2998
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536-0084
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71130-3932
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts 02115
UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska 68198-7680
North Shore University Hospital Manhasset New York 11030
SUNY Upstate Medical University Hospital Syracuse New York 13210
Duke Comprehensive Cancer Center Durham North Carolina 27710
Piedmont Hematology-Oncology Associates Winston-Salem North Carolina 27103
Gabrail Cancer Center - Canton Office Canton Ohio 44718
Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland Ohio 44106-5055
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Cancer Care Associates-West Oklahoma City Oklahoma 73112-4414
Providence Cancer Center at Providence Portland Medical Center Portland Oregon 97213
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Cancer Centers of the Carolinas - Eastside Greenville South Carolina 29615
Baylor University Medical Center Dallas Texas 75246
University of Texas - MD Anderson Cancer Center Houston Texas 77030
Fairfax Northern Virginia Hematology Oncology, P.C. - Fairfax Fairfax Virginia 22031
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226-3596

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00069966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2009 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00069966 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →